DENDREON CORP DNDN (NASDAQ)

$ 5.79
19:09
Change: unch (unch%)
Volume: 895,701

Avg. Volume: 1228640
P/E Ratio: 0
EPS (Annual): -0.96
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 93,200
Institutional Shareholders: 37.61%
Last: 5.79
Change: unch (unch%)
Prev. Close: 5.79
Open: 5.97
Day's Range: 5.77 - 5.97
52wk Range: 4.15 - 8.56
Market Value: 549,300
Beta: 1.59
12-month EPS Change: 0.00%
Total Return Last 12 Months: -25.48%
Total Return Last 3 Years: -3.35%
Total Return Last 5 Years: -33.52%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on DNDN
Alert me Subscribe

Cell Genesys at all-time low after GVAX trial ends

(NEW YORK)Shares of Cell Genesys Inc. crashed to an all-time low Wednesday after the company stopped a clinical trial of its prostate cancer vaccine GVAX because of patient deaths.READ MORE
Aug 27, 2008 5:00PM
Keywords: CEGE, DNDN, SNY, SFY

Premarket Movers: TICC Falls

(NEW YORK)Shares of financial and biotechnology companies were among the active stocks in premarket trading Friday. TICC Capital Corp., a financial firm that provides capital to small and mi...READ MORE
Mar 14, 2008 8:00AM
Keywords: TICC, DNDN, TTHI, YHOO, MSFT

Earnings Roundup: Eddie Bauer

Among the earnings stories for Thursday, March 13, from AP Financial News: SEATTLE (AP) _ Apparel retailer Eddie Bauer Holdings Inc. on Thursday said it swung to a fourth-quarter l...READ MORE
Mar 13, 2008 5:33PM
Keywords: EBHI, DNDN, HIBB, PSUN

Dendreon 4Q Loss Widens on R&D Costs

(SEATTLE)Biotechnology company Dendreon Corp. said Thursday its fourth-quarter loss widened on higher research and development costs. The company, which develops drugs to help the immune sy...READ MORE
Mar 13, 2008 9:53AM
Keywords: DNDN

Dendreon and FDA Bump Up Trial Timeline

(SEATTLE)Dendreon Corp. said Wednesday the Food and Drug Administration agreed to an accelerated timeline for its late-stage clinical trial of Provenge, the biotechnology company's prostate...READ MORE
Mar 12, 2008 8:52AM
Keywords: DNDN, CEGE

Cell Genesys Shares Continue Climb

(NEW YORK)Shares of Cell Genesys Inc. continued climbing Tuesday, following last week's report showing its vaccine candidate helped prostate cancer patients live longer in a midstage study.READ MORE
Feb 19, 2008 1:40PM
Keywords: CEGE, DNDN

Premarket Movers: Baidu.com Gains

(NEW YORK)Shares of Baidu.com gained in premarket trading Thursday after the Chinese search engine reported a 79 percent jump in fourth-quarter profit. The Beijing-based company said online ...READ MORE
Feb 14, 2008 9:23AM
Keywords: CMCSA, DNDN, INTC, NVDA, BIDU
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +30.20 60.88
AMYLIN PHARMA I -55.90 21.48
GILEAD SCIENCES +22.60 49.98
BIOGEN IDEC INC -21.40 48.16
GENENTECH INC +33.70 96.50